Markets › United States › NYSE › RCUS

Arcus Biosciences Inc

NYSE:RCUSHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$18.70−3.41%LiveIn session · ≈ AED 68.68 · Market cap $2.38B · Next earnings Tue 27 Oct

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-08-05	−0.89	−0.72	+19.0%	22.0	41.0	+86.5%
2026-05-05	−0.92	−1.02	−10.9%	29.5	17.0	−42.3%
2026-02-25	−1.11	−0.89	+19.8%	35.7	33.0	−7.6%
2025-10-28	−1.33	−1.27	+4.5%	24.9	26.0	+4.3%
2025-08-06	−1.14	−0.08	+93.4%	32.5	160.0	+392.6%
2025-05-06	−1.02	−1.14	−11.8%	37.4	28.0	−25.0%
2025-02-25	−1.17	−1.03	+12.0%	29.4	26.0	−11.5%
2024-11-06	−1.07	−1.00	+6.5%	32.1	48.0	+49.7%
2024-08-08	−1.02	−1.02	+0.0%	25.6	39.0	+52.3%
2024-05-08	−0.97	−0.05	+94.8%	35.6	145.0	+307.8%
2024-02-21	−1.09	−1.08	+0.9%	28.2	31.0	+10.0%
2023-11-07	−1.12	−0.94	+16.1%	28.3	32.0	+13.0%